fbpx
  • Home
  • Study Details
Open

Treatment Study for Non-diabetic Chronic Kidney Disease (FIND-CKD)

The purpose of this study is to look at how well the new investigational drug works in participants with non-diabetic chronic kidney disease. An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA). Additionally, finerenone is approved for use in patients with chronic kidney disease with diabetes, but this study will evaluate whether the new drug is safe for the participants with chonic kidney disease without diabetes and will determine how it affects the body.

Age & Gender

  • 18 years ~ 0 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)
  • In-home visits available

Location

North Carolina (Statewide)

What will be asked of you

You will be required to take 1 tablet of finerenone or placebo once daily. You will be asked to provide blood and urine samples and to fill out a questionnaire at each in-person study visit. Vital sings (pulse, blood pressure) will be collected at each-visit. An electrocardiogram (a test to see how your heart works) will be performed several times throughout the study.

Incentives

$85 will be provide for completion of each in-person visit

In-person visits:
13-18
Phone or online visits:
0-5
Total length of participation:
3-4 years

Looking for Specific Volunteers

Able to participate:

  • You have been diagnosed with chronic kidney disease
  • You have NOT been diagnosed with diabetes

Not eligible if:

  • You have been diagnosed with diabetes
  • You have been treated with an immunosuppressive medication in the last 6 months
  • You have had a kidney transplant

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Visit Study Website

Primary Visit Location

Eastwone Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Amy Mottl
Medicine-Nephrology

Study Type

Clinical or Medical
Interventional

Study Topics

Kidneys and Liver

IRB Number

21-3122

ClinicalTrials.gov

NCT05047263

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research